MENU
ITRM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Iterum Therapeutics (ITRM) Earnings Date & Reports

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

ITRM is expected to report earnings to fall 106.25% to 0 cents per share on March 12

Iterum Therapeutics ITRM Stock Earnings Reports
Q4'25
Est.
$0.01
Q3'25
Missed
by $0.05
Q2'25
Missed
by $0.02
Q1'25
Beat
by $0.05
Q4'24
Beat
by $0.10
The last earnings report on November 14 showed earnings per share of -15 cents, missing the estimate of -10 cents. With 609.69K shares outstanding, the current market capitalization sits at 19.53M.
View a ticker or compare two or three
ITRM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ITRM showed earnings on November 14, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

an operator, which engages in the healthcare industry focusing on biotechnology business

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
Fitzwilliam Court
Phone
+353 16694820
Employees
14
Web
https://www.iterumtx.com